|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                              |                                               |                 |                                 |                         |                       |                                                  |                   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|----------------------------------------------|-----------------------------------------------|-----------------|---------------------------------|-------------------------|-----------------------|--------------------------------------------------|-------------------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
| Three Months Ended March 31, 2023            |                                               |                 |                                 |                         |                       |                                                  |
| Percentage change versus the year-ago period |                                               |                 |                                 |                         |                       |                                                  |
|                                              | Reported(GAAP)Net SalesGrowth/ (Decrease) | Reported Volume | Acquisitions & Divestitures | Foreign Exchange Impact | PriceMix andOther (1) | OrganicSalesGrowth/ (Decrease)(Non-GAAP) (2) | OrganicVolume (3) |  |  |  |  |  |  |
| Health and Wellness                          | 7%                                            | (16)%           | —%                        | —%                | 23%                   | 7%                                               | (16)%             |  |  |  |  |  |  |
| Household                                    | 2                                             | (12)            | —                         | —                 | 14                    | 2                                                | (12)              |  |  |  |  |  |  |
| Lifestyle                                    | 15                                            | —         | —                         | —                 | 15                    | 15                                               | —           |  |  |  |  |  |  |
| International                                | 1                                             | (7)             | —                         | (13)                    | 21                    | 14                                               | (7)               |  |  |  |  |  |  |
| Total                                        | 6%                                            | (11)%           | —%                        | (2)%                    | 19%                   | 8%                                               | (11)%             |  |  |  |  |  |  |
|                                              |                                               |                 |                                 |                         |                       |                                                  |                   |  |  |  |  |  |  |
|                                              |                                               |                 |                                 |                         |                       |                                                  |                   |  |  |  |  |  |  |
| Nine Months Ended March 31, 2023             |                                               |                 |                                 |                         |                       |                                                  |
| Percentage change versus the year-ago period |                                               |                 |                                 |                         |                       |                                                  |
|                                              | Reported(GAAP)Net SalesGrowth/ (Decrease) | Reported Volume | Acquisitions & Divestitures | Foreign Exchange Impact | PriceMix andOther (1) | OrganicSalesGrowth/ (Decrease)(Non-GAAP) (2) | OrganicVolume (3) |  |  |  |  |  |  |
| Health and Wellness                          | —%                                      | (19)%           | —%                        | —%                | 19%                   | —%                                         | (19)%             |  |  |  |  |  |  |
| Household                                    | 2                                             | (8)             | —                         | —                 | 10                    | 2                                                | (8)               |  |  |  |  |  |  |
| Lifestyle                                    | 5                                             | (6)             | —                         | —                 | 11                    | 5                                                | (6)               |  |  |  |  |  |  |
| International                                | (1)                                           | (6)             | —                         | (11)                    | 16                    | 10                                               | (6)               |  |  |  |  |  |  |
| Total                                        | 1%                                            | (12)%           | —%                        | (2)%                    | 15%                   | 3%                                               | (12)%             |  |  |  |  |  |  |

|                                                                                                                                                                                                                                                                                                                                                                                                          |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
|                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                          |
|                                                                                                                                                                                                                                                                                                                                                                                                          |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                          |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                          |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                          |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                          |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                          |  |  |  |  |  |  |  |
|                                                                                                                                                                                                                                                                                                                                                                                                          |
| (1) This represents the net impact on net sales growth / (decrease) from pricing actions, mix and other factors.                                                                                                                                                                                                                                                                                     |
| (2) Organic sales growth / (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See “Non-GAAP Financial Information” below for reconciliation of organic sales growth / (decrease) to net sales growth / (decrease), the most directly comparable GAAP financial information. |
| (3) Organic volume represents volume excluding the effect of any acquisitions and divestitures.                                                                                                                                                                                                                                                                                                          |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                                       |                                              |           |           |               |         |  |  |  |  |  |  |  |  |  |  |  |  |
|-------------------------------------------------------|----------------------------------------------|-----------|-----------|---------------|---------|--|--|--|--|--|--|--|--|--|--|--|--|
|                                                       | Three Months Ended March 31, 2023            |
|                                                       | Percentage change versus the year-ago period |
|                                                       | Health and Wellness                          | Household | Lifestyle | International | Total   |
| Net sales growth / (decrease) (GAAP)              | 7%                                           | 2%        | 15%       | 1%            | 6%      |
| Add: Foreign Exchange                             | —                                      | —   | —   | 13            | 2       |
| Add/(Subtract): Divestitures/Acquisitions | —                                      | —   | —   | —       | — |
| Organic sales growth / (decrease) (non-GAAP)      | 7%                                           | 2%        | 15%       | 14%           | 8%      |
|                                                       |                                              |           |           |               |         |
|                                                       |                                              |           |           |               |         |
|                                                       | Nine Months Ended March 31, 2023             |
|                                                       | Percentage change versus the year-ago period |
|                                                       | Health and Wellness                          | Household | Lifestyle | International | Total   |
| Net sales growth / (decrease) (GAAP)              | —%                                     | 2%        | 5%        | (1)%          | 1%      |
| Add: Foreign Exchange                             | —                                      | —   | —   | 11            | 2       |
| Add/(Subtract): Divestitures/Acquisitions | —                                      | —   | —   | —       | — |
| Organic sales growth / (decrease) (non-GAAP)      | —%                                     | 2%        | 5%        | 10%           | 3%      |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                               |                                                         |        |       |       |       |       |       |       |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|-------------------------------|---------------------------------------------------------|--------|-------|-------|-------|-------|-------|-------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
| Driver                        | Gross Margin Change vs. Prior Year (basis points)  |        |
| FY22                          | FY23                                                    |        |
| Q1                            | Q2                                                      | Q3     | Q4    | FY    | Q1    | Q2    | Q3    |       |
| Cost Savings                  | +90                                                     | +80    | +100  | +160  | +110  | +180  | +170  | +150  |  |
| Price Changes                 | +50                                                     | +100   | +170  | +330  | +160  | +530  | +680  | +750  |  |
| Market Movement (commodities) | -550                                                    | -510   | -410  | -350  | -460  | -330  | -240  | -230  |  |
| Manufacturing & Logistics | -470                                                    | -640   | -570  | -290  | -490  | -350  | -100  | -120  |  |
| All other (1) (2) (3) (4)     | -210                                                    | -270   | -50   | +150  | -100  | -140  | -190  | +40   |  |
| Change vs prior year          | -1,090                                                  | -1,240 | -760  | 0     | -780  | -110  | +320  | +590  |  |
|                          |                                                    |        |       |       |       |       |       |       |  |
| Gross Margin (%)              | 37.1%                                                   | 33.0%  | 35.9% | 37.1% | 35.8% | 36.0% | 36.2% | 41.8% |  |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                                                  |                   |  |                         |  |  |  |  |  |  |  |  |
|------------------------------------------------------------------|-------------------|--|-------------------------|--|--|--|--|--|--|--|--|
|                                                             | Q3 Fiscal YTD2023 |  | Q3 Fiscal YTD 2022 |
| Net cash provided by operations – GAAP                     | $728              |  | $451                    |
| Less: Capital expenditures                                   | $144              |  | $172                    |
| Free cash flow – non-GAAP (1)                              | $584              |  | $279                    |
| Free cash flow as a percentage of net sales – non-GAAP (1) | 10.9%             |  | 5.3%                    |
| Net sales                                                        | $5,370            |  | $5,306                  |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                                                   |                   |        |                    |        |                   |        |                   |        |                   |       |                   |      |                    |      |                   |        |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|-------------------------------------------------------------------|-------------------|--------|--------------------|--------|-------------------|--------|-------------------|--------|-------------------|-------|-------------------|------|--------------------|------|-------------------|--------|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
|                                                              | FY 2022           |        | FY 2023            |
|                                                              |              |   |               |   |              |   |              |   |              |       |                   |      |                    |      |                   |
|                                                              | Q1                |        | Q2                 |        | Q3                |        | Q4                |        | FY                |       | Q1                |      | Q2                 |      | Q3                |
|                                                              | 9/30/2021 |        | 12/31/2021 |        | 3/31/2022 |        | 6/30/2022 |        | 6/30/2022 |       | 9/30/2022 |      | 12/31/2022 |      | 3/31/2023 |
| Earnings before income taxes                                      | $185              |        | $93                |        | $200              |        | $129              |        | $607              |       | $116              |      | $130               |      | -$245             |
| Interest income                                                   | -$1               |        | -$1                |        | -$1               |        | -$2               |        | -$5               |       | -$2               |      | -$3                |      | -$4               |
| Interest expense                                                  | $25               |        | $23                |        | $21               |        | $37               |        | $106              |       | $22               |      | $23                |      | $24               |
| EBIT(1)(3)                                                        | $209              |        | $115               |        | $220              |        | $164              |        | $708              |       | $136              |      | $150               |      | -$225             |
| EBIT margin (1)(3)                                                | 11.6%             |        | 6.8%               |        | 12.2         | %      |                   | 9.1%   |                   | 10.0% |                   | 7.8% |                    | 8.7% |                   | -11.7% |
| VMS impairment (4)                                                | $0                |        | $0                 |        | $0                |        | $0                |        | $0                |       | $0                |      | $0                 |      | $445              |
| Streamlined operating model (5)                                   | $0                |        | $0                 |        | $0                |        | $0                |        | $0                |       | $19               |      | $4                 |      | $21               |
|                                                                   |                   |        |                    |        |                   |        |                   |        |                   |       |                   |      |                    |      |                   |
| Digital capabilities and productivity enhancements investment (6) | $12               |        | $15                |        | $15               |        | $19               |        | $61               |       | $20               |      | $25                |      | $28               |
| Adjusted EBIT – non-GAAP (2)(3)                             | $221              |   | $130               |        | $235              |        | $183              |        | $769              |       | $175              |      | $179               |      | $269              |
| Adjusted EBIT margin (2)(3)                                       | 12.2%             |        | 7.7%               |        | 13.0%             |        | 10.2%             |        | 10.8%             |       | 10.1%             |      | 10.4%              |      | 14.0%             |
| Net sales                                                         | $1,806            |        | $1,691             |        | $1,809            |        | $1,801            |        | $7,107            |       | $1,740            |      | $1,715             |      | $1,915            |
|                                                              |              |   |               |   |              |   |              |   |              |       |                   |      |                    |      |                   |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |

----

|                    |  |  |  |  |  |  |  |  |
|--------------------|--|--|--|--|--|--|--|--|
| The Clorox Company |  |  |

|                                             |                                                                   |  |                                          |                                     |                            |                             |          |          |               |           |               |               |               |            |   |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|---------------------------------------------|-------------------------------------------------------------------|--|------------------------------------------|-------------------------------------|----------------------------|-----------------------------|----------|----------|---------------|-----------|---------------|---------------|---------------|------------|---|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|--|
| (Dollars in millions except per share data) |                                                                   |  |                                          |                                     |                            |                             |          |          |               |
|                                             |                                                                   |  |                                          | Diluted Earnings (Losses) per Share |                            | Effective Tax Rate          |          |
|                                             |                                                                   |  |                                          | Three Months Ended March 31         |                            | Three Months Ended March 31 |          |
|                                             |                                                                   |  |                                          | 2023                                |                            | 2022                        |          | % Change |               | 2023      |               | 2022          |               |
|                                             | As reported (GAAP)                                                |  | $                                        | (1.71)                              |                            | $                           | 1.21     |          | (241)%        |           | 14.7     | %             |               | 23.9  | % |  |
|                                             | VMS impairment (1)(2)                                             |  | 2.92                                     |                                     | —                    |                             |          |          | 9.1      | %         |               | —  |               |            |
|                                             | Streamlined operating model (3)                                   |  | 0.13                                     |                                     | —                    |                             |          |          | —  |           |               | —  |               |            |
|                                             | Digital capabilities and productivity enhancements investment (4) |  | 0.17                                     |                                     | 0.10                       |                             |          |          | —  | %         |               | —  | %             |            |
|                                             | As adjusted (Non-GAAP) (7)(8)                                     |  | $                                        | 1.51                                |                            | $                           | 1.31     |          | 15%           |           | 23.8     | %             |               | 23.9  | % |  |
|                                             |                                                                   |  |                                          |                                     |                            |                             |          |          |               |           |               |               |
|                                             |                                                                   |  | Diluted Earnings (Losses) per Share      |                                     | Effective Tax Rate         |                             |
|                                             |                                                                   |  | Nine Months Ended March 31               |                                     | Nine Months Ended March 31 |                             |
|                                             |                                                                   |  | 2023                                     |                                     | 2022                       |                             | % Change |          | 2023          |           | 2022          |               |
|                                             | As reported (GAAP)                                                |  | $                                        | (0.22)                              |                            | $                           | 2.91     |          | (108)%        |           | 1,813.5  | %             |               | 23.3  | % |  |
|                                             | VMS impairment (1)(2)                                             |  | 2.92                                     |                                     | —               |                             |          |          |               | (1,790.2) | %             |               | —  |            |   |
|                                             | Streamlined operating model (3)                                   |  | 0.27                                     |                                     | —                    |                             |          |          | —  |           |               | —  |               |            |
|                                             | Digital capabilities and productivity enhancements investment (4) |  | 0.45                                     |                                     | 0.26                       |                             |          |          | 0.1      | %         |               | 0.1      | %             |            |
|                                             | As adjusted (Non-GAAP) (7)(8)                                     |  | $                                        | 3.42                                |                            | $                           | 3.17     |          | 8%            |           | 23.4     | %             |               | 23.4  | % |  |
|                                             |                                                                   |  |                                          |                                     |                            |                             |          |          |               |           |               |               |
|                                             |                                                                   |  | Full Year 2023 Outlook (Estimated Range) |                                     |                            |                             |
|                                             |                                                                   |  | Diluted Earnings Per Share               |                                     | Effective Tax Rate         |                             |          |          |
|                                             |                                                                   |  | Low                                      |                                     | High                       |                             | Midpoint |          |               |           |
|                                             | As estimated (GAAP)                                               |  | $                                        | 0.45                                |                            | $                           | 0.60     |          | 37%           |           |               |               |
|                                             | VMS impairment                                                    |  | 2.92                                     |                                     | 2.92                       |                             | (13)%    |          |               |           |
|                                             | Streamlined operating model (5)                                   |  | 0.35                                     |                                     | 0.35                       |                             | —% |          |               |           |
|                                             | Digital capabilities and productivity enhancements investment (6) |  | 0.63                                     |                                     | 0.63                       |                             | —% |          |               |           |
|                                             | As adjusted (Non-GAAP) (7)(8)                                     |  | $                                        | 4.35                                |                            | $                           | 4.50     |          | 24%           |           |               |               |
|                                             |                                                                   |  |                                          |                                     |                            |                             |          |          |               |           |               |               |               |

|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |
|  |  |  |  |  |  |  |  |  |
|--|--|--|--|--|--|--|--|--|
|  |  |  |